Table 1.

Patient characteristics

Patient No	Age	Gender	WHO Grade	Histopathology	IDH mutation status	Primary treatment received
1	35	Male	III	Oligodendroglioma	Mutant	Surgery, concurrent CT/RT
2	66	Male	IV	GBM	Wild-type	Surgery, concurrent CT/RT, adjuvant TMZ
3	39	Female	IV	GBM	Mutant	Surgery, concurrent CTRT, redo surgery, adjuvant TMZ
4	52	Female	IV	GBM	Non contributory	Surgery, concurrent CTRT, adjuvant TMZ
5	42	Male	III	Astrocytoma	Mutant	Surgery, concurrent CTRT
6	47	Male	IV	GBM	Wild-type	Surgery, concurrent CTRT, adjuvant TMZ

CT/RT: chemotherapy and radiation therapy; TMZ: temozolamide; GBM: glioblastoma